MASI · Masimo Corp
Market Cap
$9.42B
Shares
52.37M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.53B
+9.4%
FY2025
Net Income
-$151.5M
+50.3%
FY2025
Gross Margin
61.9%
+5pp
FY2025
Operating Margin
20.3%
+15.8pp
FY2025
Diluted EPS
-$2.80
+50%
FY2025
Operating Cash Flow
$217.8M
+10.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.56B | $1.53BG | $1.4BG | $1.28B | $2.04B | $1.24B | $1.14B | $937.84M | $858.29M | $790.25M | $712.9M | $630.11M | $586.64M | $547.25M | $493.23M | $438.99M | $405.41M | $349.12M | $307.07M | |
| $596.5M | $581.7M | $600.9M | $509.9M | $977M | $430.8M | $400.7M | $308.67M | $283.4M | $268.22M | $234.56M | $220.13M | $195.86M | $188.42M | $166.98M | $144.85M | $119.83M | $100.31M | $89.45M | |
| $962M | $945.2M | $794.3M | $765.6M | $1.06B | $808.4M | $743M | $629.17M | $574.89M | $522.03M | $478.34M | $409.98M | $390.78M | $358.83M | $326.25M | $294.13M | $285.58M | $248.8M | $217.62M | |
| — | 61.9% | 56.93% | 60.02% | 52.01% | 65.24% | 64.96% | 67.09% | 66.98% | 66.06% | 67.1% | 65.07% | 66.61% | 65.57% | 66.15% | 67% | 70.44% | 71.27% | 70.87% | |
| $122.5M | $126.4M | $182.2M | $130.5M | $191.4M | $137.2M | $118.7M | $93.3M | $81.01M | $65.23M | $57.69M | $56.62M | $56.58M | $55.63M | $47.08M | $38.41M | $36M | $31.7M | $25.5M | |
| $530M | $506M | $548.6M | $451.3M | $657.4M | $395.4M | $369M | $314.66M | $285.42M | $273.01M | $254.71M | $252.73M | $241.02M | $215.47M | $193.95M | $169.21M | $174.09M | $134.58M | $120.07M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $1.5M | $2.1M | $1.6M | $1.3M | — | — | |
| — | $38.8M | $48.5M | $38.9M | $136.1M | $35.6M | $29.3M | $23.49M | $21.13M | $20.06M | $16.82M | $15.68M | $12.82M | $11.42M | $9.37M | $7.34M | $6.58M | $5.98M | $5.75M | |
| $652.6M | $635.2M | $731.3M | $599.6M | $848.8M | $532.6M | $487.2M | $407.96M | $366.85M | $338.25M | $42.39M | $289.73M | $287.27M | $279.11M | $241.03M | $207.62M | $179.36M | $166.58M | $146.27M | |
| $309.4M | $310M | $63M | $166M | $210M | $275.8M | $255.8M | $221.22M | $208.04M | $183.79M | $435.95M | $120.25M | $103.51M | $79.72M | $85.23M | $86.52M | $106.22M | $82.23M | $71.35M | |
| — | 20.3% | 4.52% | 13.01% | 10.32% | 22.26% | 22.37% | 23.59% | 24.24% | 23.26% | 61.15% | 19.08% | 17.64% | 14.57% | 17.28% | 19.71% | 26.2% | 23.55% | 23.24% | |
| — | $348.8M | $111.5M | $204.9M | $346.1M | $311.4M | $285.1M | $244.7M | $229.17M | $203.85M | $452.76M | $135.93M | $116.33M | $91.14M | $94.6M | $93.86M | $112.81M | $88.21M | $77.1M | |
| $30.5M | $33.2M | $41.2M | $50.3M | $25.7M | $300K | $300K | $328K | $706K | $678K | $3.26M | — | — | — | — | — | — | — | — | |
| -$33.9M | -$37.4M | -$41.2M | -$53M | -$16.6M | -$1.4M | $7.9M | $12.95M | $5.73M | $2.01M | -$2.43M | -$3.91M | -$1.47M | -$3.99M | -$1.41M | $14K | $1.35M | -$46K | $1.04M | |
| $275.5M | $272.6M | $21.8M | $113M | $193.4M | $274.4M | $263.7M | $234.17M | $213.78M | $185.8M | $433.52M | $116.35M | $102.04M | $75.73M | $83.82M | $86.53M | $107.57M | $82.18M | $72.39M | |
| $58.7M | $64.9M | $5.6M | $5.3M | $49.9M | $44.8M | $23.4M | $37.95M | $20.23M | $61.01M | $122.42M | $34.85M | $27.68M | $20.01M | $21.88M | $22.48M | $34.16M | $28.16M | $40.46M | |
| $76.3M | -$151.5M | -$304.9M | $81.5M | $143.5M | $229.6M | $240.3M | $196.22M | $193.54M | $124.79M | $311.1M | $83.3M | $72.52M | $58.38M | $62.27M | $63.7M | $73.53M | $53.23M | $31.93M | |
| — | -9.92% | -21.85% | 6.39% | 7.05% | 18.53% | 21.01% | 20.92% | 22.55% | 15.79% | 43.64% | 13.22% | 12.36% | 10.67% | 12.63% | 14.51% | 18.14% | 15.25% | 10.4% | |
| — | — | — | — | — | — | -$20K | $0 | $0 | $0 | $0 | -$1.8M | $1.85M | -$2.66M | -$334K | $353K | -$125K | $794K | — | |
| $149.2M | -$55.8M | -$367.8M | $24.7M | $160.5M | $222.7M | $248.4M | $195.7M | $190.29M | $135.7M | $298.38M | $80.65M | $66.43M | $58.83M | $64.54M | $64.05M | $74.39M | $54.09M | $32.95M | |
| USD/shares | — | -$2.83 | -$5.72 | $1.54 | $2.68 | $4.16 | $4.39 | $3.67 | $3.70 | $2.42 | $6.28 | $1.62 | $1.33 | $1.03 | $1.08 | $1.07 | $1.25 | $0.92 | $0.57 |
| USD/shares | — | -$2.80G | -$5.60G | $1.51 | $2.60 | $3.98 | $4.14 | $3.44 | $3.45 | $2.23 | $5.85 | $1.55 | $1.30 | $1.02 | $1.07 | $1.05 | $1.21 | $0.88 | $0.53 |
| shares | — | 53.6M | 53.3M | 52.8M | 53.6M | 55.2M | 54.7M | 53.43M | 52.3M | 51.52M | 49.53M | 51.31M | 54.71M | 56.69M | 57.45M | 59.66M | 58.77M | 57.6M | 56.32M |
| shares | — | 54.2M | 54.4M | 54.1M | 55.2M | 57.7M | 58M | 57.1M | 56.04M | 55.87M | 53.2M | 53.71M | 55.57M | 57.48M | 58.37M | 60.85M | 60.61M | 60.17M | 60.19M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.53B in buybacks, $219.27M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
6.26×
Peer median 3.09×
EV/EBIT
31.51×
Peer median 24.33×
P/E (TTM)
—
Peer median 28.36×
Peer medians compare against the 36 similar-size Medical Devices companies (of 148 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Health Care Segment | $1,524,100,000 | $1,395,200,000 | $1,275,500,000 | $1,340,300,000 | $1,239,200,000 | $1,143,700,000 |
| Non Healthcare | — | — | — | $695,500,000 | $0 | $0 |
Key facts
CIK
937556
CUSIP
574795100
13F (30d)
11 filings
10 filers
Visit website
Investor relations